Upscale AI | $5,500,000 | (May 13, 2025)
GLASS Imaging | $20,000,000 | (May 13, 2025)
theom | $20,000,000 | (May 13, 2025) Certified by Founder
Lodge
Delphia Therapeutics
start up
United States
- Cambridge, Massachusetts
- 07/05/2024
- Series A
- $67,000,000
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.
- Industry Biotechnology Research
- Website https://www.delphiatx.com/
- LinkedIn https://www.linkedin.com/company/delphia-therapeutics/
Una Software | $4,400,000 | (May 9, 2025)
Zebu Intelligent Systems Pvt Ltd | $1,000,000 | (May 9, 2025)
Jozu | $4,000,000 | (May 9, 2025)
PATH EX, Inc. | $5,000,000 | (May 9, 2025)
Kouper | $10,000,000 | (May 9, 2025)
Blank Beauty | Undisclosed Amount | (May 9, 2025)
Pulse Charter Connect | $2,000,000 | (May 9, 2025)